Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc.

Pharmaceutical companies and governmental regulatory agencies are becoming increasingly aware of the need for improved statistical methods for developmental toxicity experiments. Although a number of ...

Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration that offers Charles River’s clients access to ReproTracker®, a state-of-the-art human stem ...

New Rochelle, NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus ...

(Nanowerk News) The environmental and health risks of graphene oxide (GO) attract considerable attention because of its wide-ranging applications in various field. GO, an extensively studied carbon ...

Before the safety and efficacy of a new vaccine can be evaluated in a Phase I clinical trial with human subjects, it must first undergo non-clinical safety evaluation in animal models. Regulatory ...

Cancer is diagnosed relatively rarely in pregnant women. It occurs in about 1 in 1000 pregnancies. Treating cancer in pregnant women is complex. The goal is to optimize cancer treatment while ...